AI Insights. Real Growth. Higher GMV, Better Profits

The difference between growing stores and stagnant ones isn't more effort. It's better insights. StoreClaw analyzes your Shopify and Amazon data, surfaces your biggest growth opportunities, and helps you increase GMV while protecting profit. Start free with bonus tokens. No credit card required.

THE WEEK OF AUGUST 31, 2026

GET READY…

San Francisco will be quiet this week — Burning Man seems to clear out the city every year.. But there will be plenty of news dumping out pre-Labor Day, not least Dell (DELL:NYSE) and Broadcom (AVGO:Nasdaq) earnings midweek which will give us yet another read on the AI capital expenditures and, specific to Broadcom, a counterpoint to NVIDIA’s (NVDA:NASDAQ) POV of the XPU battles.

Our repository of former notes and searchable research database is at https://epistrophy.beehiiv.com.

Check it out!

LET’S GO 👇

Suprematist Composition: Airplane Flying
by Kazimir Malevich, 1915
Colored geometric shapes drift free of any horizon or ground — an abstracted flying object reduced to pure form, with nothing beneath it to orient the viewer. A fitting stand-in for a drone that no longer navigates by any fixed reference point (GPS) but by its own onboard AI-driven logic.
SOURCE: MoMA

Table of Contents

Last Week…

The Drill Down Podcasts 🎙️

Drill Down Earnings, Ep. 467: Fabrinet Q4 earnings – ($FN) – A Deep Dive with Cory Johnson

THE DRILL DOWN

Drill Down Earnings, Ep. 467: Fabrinet Q4 earnings – ($FN) – A Deep Dive with Cory Johnson

00:00
00:00

Drill Down Earnings summary,
Ep. 473:

Marvell Technology Q2 earnings – ($MRVL) – A Deep Dive with Cory Johnson

Drill Down Earnings summary,
Ep. 472

Elastic Q1 earnings – ($ESTC) – A Deep Dive with Cory Johnson

TWEET OF THE WEEK

EPISTROPHY IN THE NEWS 🗞️

On Schwab Network with Marley Kaden and Sam Vardas, talking about Synopsis important quarter, predicting the great success the company is having with it’s newly acquired Ansys business.

On NewsNation with Connell McShane I dissected Nvidia (NVDA: NASDAQ) earnings and the impact of the NIMBY data center fight — in short, I don’t see one.

AVAILABILITY NEXT WEEK

In San Francisco all week and available for interviews, background or client calls — and as we get closer to IPO filings from Anthropic and OpenAI, we’ll be ready!.

Written reports are available to clients, our IPO reports for $5,000. Video summaries on YouTube, and of course our popular summaries of the summaries on Instagram, TikTok, and YouTube Shorts.

THE WEEK AHEAD 📆

TICKER

NAME

MARKET CAP

DATE

TYPE

CRWD

Fal.Con

$222 B

Aug 31

Conference

AVGO

VMware Explore

$1,755 B

Aug 31

Conference

PANW

Palo Alto Networks

$303 B

Sep 1

Earnings

MDB

Mongodb

$36 B

Sep 1

Earnings

DELL

Dell Technologies

$295 B

Sep 1

Earnings

CSP

Construction Spending

Sep 1

Economic Event

NTAP

NetApp

$37 B

Sep 2

Earnings

AVGO

Broadcom

$1,755 B

Sep 2

Earnings

HPE

Hewlett Packard Enterprise

$69 B

Sep 2

Earnings

SNOW

Snowflake

$114 B

Sep 2

Earnings

AI

$2 B

Sep 2

Earnings

DG_FULL

Factory Orders (M3 Full Report)

Sep 2

Economic Event

CRWD

Investor Briefing (Fal.Con)

Sep 2

Investor Day

ZS

Zscaler

$30 B

Sep 3

Earnings

CIEN

Ciena

$54 B

Sep 3

Earnings

DOCU

Docusign

$12 B

Sep 3

Earnings

EMPSIT

Employment Situation

Sep 4

Economic Event

🎉

Labor Day

Sep 7

Market Holiday

MELI

Mercado Libre Experience (Mexico)

Sep 9

Conference

ADBE

Adobe

$116 B

Sep 10

Earnings

PPI

Producer Price Index

Sep 10

Economic Event

MELI

Mercado Libre Experience (Argentina)

Sep 10

Conference

CPI

Consumer Price Index

Sep 11

Economic Event

We certify that (1) the views expressed in this report accurately reflect our views about all of the subject companies and securities and (2) no part of my compensation was, is or will be directly related to the specific recommendations or views expressed in this report.

Important disclosures

Important disclosures are available by calling (347) 619-2489 or writing to Epistrophy Capital Research, One Ferry Building, Suite 201, San Francisco, CA 94105.

Epistrophy Capital Research is an independent research provider and does not operate as a financial institution. Epistrophy explicitly does not provide investment advice, stock recommendations, or solicitations to buy or sell any securities.

The research reports provided by Epistrophy Capital Research contain opinions derived from publicly available information, issuer communications, recognized statistical services, and other reputable sources considered reliable. However, Epistrophy does not independently verify the accuracy or completeness of such information and explicitly disclaims responsibility for any errors or omissions.

Opinions and analysis contained within Epistrophy's research reports are current only at the time of publication and are subject to change without notice. Readers must independently verify facts and conduct their own due diligence before making investment decisions.

Epistrophy Capital Research does not consider or evaluate individual investor circumstances, including investment objectives, financial situations, or risk tolerance. Investing in securities, particularly small-cap and micro-cap stocks, involves substantial risks, including significant volatility and potential loss of principal. Readers are strongly advised to consult their financial advisor or another qualified professional before acting on any information provided. Readers should assume Epistrophy Capital Research, its principals or its contributors may have positions, long or short, any of the companies discussed and the Epistrophy Capital Research principals or contributors may have had or currently have business interests in the companies discussed.

Past performance referenced in Epistrophy reports is not indicative of future results. Security prices can fluctuate widely, and investors should be aware that investments can result in significant financial losses. Epistrophy Capital Research or its Unless explicitly stated otherwise, prices quoted in reports reflect market closing prices from the previous trading day.

Epistrophy Capital Research publications are intended solely for direct recipients and should not be redistributed or shared with third parties without explicit permission from Epistrophy Capital Research LLC.

Epistrophy Capital Research reports are provided strictly for informational purposes and do not constitute a comprehensive analysis of any company, security, or industry. No content within these reports should be considered accounting, tax, legal, or professional advice.

Links or references to third-party websites or external resources are provided solely for informational convenience. Epistrophy Capital Research expressly disclaims endorsement of, and responsibility for, the content, accuracy, or reliability of such external information. Accessing third-party information is done entirely at the user's own risk.

For additional details, clarification, or specific inquiries regarding Epistrophy Capital Research reports, please contact Epistrophy Capital Research LLC directly

Reply

Avatar

or to participate